维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Brizzi MP"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Down-regulation of phosphatidylinositol3-kinase/AKT/molecular target of Rapamycin metabolic pathway by primary Letrozole-based therapy in human breast cancer显示文摘	Generali D Fox SB Brizzi MP	2008	Clin Cancer Res2008，14，9：	1
2	Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy 显示文摘	Tampellini M Brizzi MP Bitossi R	2007	J Cancer Res Clin Oncol2007，133，10：	1
3	Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients 显示文摘	Bottini A Generali D Brizzi MP	2006	J Clin Oncol2006，24，22：	1
4	Randomized phase Ⅱ trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients显示文摘	Bottini A Generali D Brizzi MP	2006	J Clin Oncol2006，24，22：	1
5	Hypoxia-inducible factor- 1 alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer显示文摘	Generali D Berruti A Brizzi MP	2006	Clin Cancer Res2006，12，15：	1
6	Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer显示文摘	Bottini A Berruti A Brizzi MP	2003	Br J Cancer2003，89，6：	1
7	Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients显示文摘	Bottini A Generali D Brizzi MP	2006	J Clin Oncol2006，24，22：	1
8	Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization study 显示文摘	Tampellini M Bitossi R Brizzi MP	2004	Tumori2004，90，1：	1
9	Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer显示文摘	Generali D Berruti A Brizzi MP	2006	Clin Cancer Res2006，12，15：	1
10	Hypoxia-inducible factor-1(alpha) expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer显示文摘	Generali D Berruti A Brizzi MP	2006	Clin Cancer Res2006，12，15：	1
11	Pretreatment haemoglobin levels signifi- cantly predict the tumour response to primary chemotherapy in human breast cancer显示文摘	Bottini A Berruti A Brizzi MP	2003	Br J Cancer2003，89，6：	1
12	Randomized phase Ⅱ trial of letrozole and letmzole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients显示文摘	Bottini A Generali D Brizzi MP	2006	J Clin Oncol2006，24，7：	1
13	Hypoxia-inducible factor- 1 alpha expression predicts a poor response to primary chemoendocrine therapy and disease -free survival in primary human breast cancer显示文摘	Generali D Berruti A Brizzi MP	2006	Clin Cancer Res2006，12，15：	1
14	Hypoxia-inducible actor1αt expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer显示文摘	Generali D Berruti A Brizzi MP		0，，02：	1
15	Hypoxia-indueible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer 显示文摘	Generali D Berruti A Brizzi MP	2006	Clin Cancer Res2006，12，15：	1
16	Randomized phase II trial of letrozole and letrozole plus low - dosemetronomic oral cyclophosphamide asprimary systemic treatment in elderly breastcancer patients 显示文摘	Bottini A Generali D Brizzi MP	2006	J Clin Onco2006，24，22：	1
17	Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients显示文摘	Bottini A Generali D Brizzi MP	2006	J Clin Oncol2006，24，22：	1
18	Pharmacoeconomiccomparison between chronochemotherapy and FOLFOX regimenin the treatment of patients with metastatic gastric cancer: acost2minimization study显示文摘	Tampellini M Bitossi R Brizzi MP	2004	Tumori2004，90，1：	1
19	Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer:a cost-minimization study显示文摘	Tampellini M Bitossi R Brizzi MP		0，，01：	1
20	Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients显示文摘	Bottini A Generali D Brizzi MP	2006	J Clin Oncol2006，24，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示